Race Geoff 4
4 · Minerva Neurosciences, Inc. · Filed Dec 15, 2017
Insider Transaction Report
Form 4
Race Geoff
EVP and CFO
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-12-13+200,000→ 200,000 totalExercise: $6.10Exp: 2027-12-13→ Common Stock (200,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2017-12-14−12,500→ 37,500 total→ Common Stock (12,500 underlying) - Exercise/Conversion
Common Stock
2017-12-14+12,500→ 197,698 total - Sale
Common Stock
2017-12-14$5.79/sh−5,829$33,750→ 191,869 total
Footnotes (5)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock
- [F2]Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs pursuant to the terms of that certain RSU Agreement between the Reporting Person and the Issuer, as reflected in this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $5.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
- [F4]This option vests as to 25% of the shares on December 13, 2018 and then in quarterly installments over 3 years thereafter.
- [F5]Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date.